There are 461 papers on kidney failure in aging research: 28 trials and 262 observational studies in people, 27 in animals, 126 reviews. The newest story, Nov 19, 2026: “Genetic study links blood proteins to kidney disease”.
Kidney failure is linked with higher mortality after hip fracture in older adults, disability and osteoporosis in human studies. A human trial reports lower kidney failure risk with finerenone, while observational studies in chronic kidney disease link SGLT2 inhibitor use with lower risk and clonal hematopoiesis with higher risk.
92 findings in 74 papers from 2001 to 2026, 19 of them since June 2026
“Finerenone demonstrated consistent reductions in the ≥57% and ≥40% kidney composite outcomes compared with placebo, with no heterogeneity between the frailty subgroups (P values for interaction = 0.93 and 0.76, respectively; Figure ).”
Intensive blood pressure lowering showed no clear effect on kidney failure in humans With or without chronic kidney disease; compared with standard blood pressure lowering (RR 0.97 per 10-mm Hg reduction, 95% CI 0.84–1.11).
“Intensive BP lowering did not affect risk of kidney failure (RR per 10-mm Hg reduction, 0.97; 95% CI, 0.84-1.11)”
ReviewWith or without chronic kidney disease; compared with standard blood pressure lowering
Angiotensin receptor blockers were not clearly linked with kidney failure in humans (target dose versus below-target dose, veterans with HFrEF, propensity-matched ARB cohort).
“In the ARB cohort, target-dose had no association with outcomes.”
Humanstarget dose versus below-target dose, veterans with HFrEF, propensity-matched ARB cohorttarget dose5-yearn = 7,900
American journal of kidney diseases : the official journal of the National Kidney Foundation·
Survival
↓downin humans1−36% relative survival
1 study
Kidney failure is linked with lower survival in humans (incident kidney failure) (36% relative survival).
“The 5-year relative survival was 31% using standard life tables (adjusted for age, sex, race, and year) versus 36% using life tables also adjusted for comorbidities.”
American journal of kidney diseases : the official journal of the National Kidney Foundation·
Upstream
7
Systolic blood pressure
→mediatesin humans1
1 study
Systolic blood pressure is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.14% mediated).
“mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%), and systolic blood pressure (7.14%).”
HumansMediation of the relationship between body mass index and renal failure
Diastolic blood pressure is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (6.37% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
Glycated hemoglobin is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (6.83% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
Glucose is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.02% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
Cystatin C is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (12.34% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·
Kidney failure is linked with a higher risk of mortality in humans (early surgical site infection after trauma surgery) (RR = 4; 95% CI [1.81-8.85]).
“severe renal insufficiency (RR = 4; 95% CI [1.81-8.85]), and polymicrobial infection (RR = 3.61; 95% CI [1.12-11.62]) were significantly associated with mortality.”
Humansearly surgical site infection after trauma surgeryn = 40
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·
Kidney failure is linked with a higher risk of mortality in elderly adults with tuberculosis.
“mortality was significantly associated with severe renal failure, living in nursing home or long-term care facilities, and weight loss at presentation.”
SGLT2 inhibitors are linked with a lower risk of kidney failure in adults with CKD receiving specialist nephrology care (OR 0.67 (95% CI 0.52 to 0.85)).
“SGLT2 inhibitor use was associated with a lower risk of MACE (odds ratio 0.80, 95% confidence interval, 0.71 to 0.91) and KRT (0.67, 0.52 to 0.85).”
Humansin adults with CKD receiving specialist nephrology caren = 32,856
Clinical journal of the American Society of Nephrology : CJASN·
SGLT2 inhibitors are associated with kidney failure in patients with CKD.
“Sodium-glucose cotransporter 2 (SGLT2) inhibitor therapy was independently associated with lower risks of death, kidney failure, and cardiovascular events”
Journal of the American Society of Nephrology : JASN·
SGLT2 inhibitors lower the risk of kidney failure in humans (relative effect versus placebo larger in magnitude than with GLP-1-based therapies).
“They reduce risk of kidney failure and hospitalisation for heart failure, with relative effects on these outcomes versus placebo appearing larger in magnitude than effects achieved with GLP-1-based therapies.”
Diabetes mellitus is associated with kidney failure in humans.
“In octogenarians, hypertension was more strongly associated with postoperative atrial fibrillation, diabetes with renal failure, and cerebrovascular disease with discharge to extended care.”
Humansfollowing isolated coronary artery bypass grafting; stronger association than in younger patients
Finerenone lowers the risk of kidney failure in humans.
“Finerenone demonstrated consistent reductions in the ≥57% and ≥40% kidney composite outcomes compared with placebo, with no heterogeneity between the frailty subgroups (P values for interaction = 0.93 and 0.76, respectively; Figure ).”
Kidney failure is associated with osteoporosis in humans (dialysis / kidney failure) (73% (T-score ≤-2.5: 65%, fragility fracture: 41%, vertebral fracture: 13%)).
“CKD-associated osteoporosis was identified in 73% of participants, based on a T-score ≤-2.5 at the hip or lumbar spine (65%), history of fragility fracture (41%) and/or finding of a vertebral fracture (13%).”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
kidney failure risk equation predicts kidney failure in humans across eGFR equations, cohorts, multimorbidity groups and time horizons (area under curve 0.86 or higher).
“Discrimination of KFRE was good (area under curve $\ge $0.86 across eGFR equations in all cohorts, multimorbidity groups and time horizons).”
Humansacross eGFR equations, cohorts, multimorbidity groups and time horizons2 and 5 years
Clinical journal of the American Society of Nephrology : CJASN·
male sex is linked with a higher risk of kidney failure in humans (adjusted for demographics, kidney function, comorbidities, social factors, and medications) (HR 1.28, 95% CI 1.09–1.50).
“male sex was associated with a higher risk of kidney failure (hazard ratio [HR] 1.28; 95% confidence interval, 1.09 to 1.50)”
Humansadjusted for demographics, kidney function, comorbidities, social factors, and medicationsmales
Clinical journal of the American Society of Nephrology : CJASN·
Household income
↑upin humans1HR 3.08
1 study
Household income is associated with kidney failure in humans (Household income below $25,000 compared with $200,000 or more) (Adjusted HR 3.08 (95% CI 2.30–4.11)).
“Lower income was associated with higher mortality and greater risk of all kidney outcomes.”
HumansHousehold income below $25,000 compared with $200,000 or morekidneyMedian follow-up of 2.76 yearsn = 218,098
Contains public sector information licensed under the Open Government Licence v3.0.
How this record changed
Summary rewritten as its findings changed.
As it read before
Kidney failure is linked with higher mortality after hip fracture in older adults and with disability in human observational studies. A human trial reports that finerenone lowers kidney failure risk; observational studies link SGLT2 inhibitor use with lower risk in adults with chronic kidney disease receiving specialist nephrology care.
Summary rewritten as its findings changed.
As it read before
Kidney failure is linked with higher mortality in human observational studies of older adults with tuberculosis or hip fractures and older patients hospitalized with pneumonia. A human trial reports that finerenone lowers kidney failure risk, while an observational study links physical activity with lower risk.
Kidney failure is linked with higher mortality in human cohorts, including older adults with hip fractures, tuberculosis or pneumonia, and with disability and osteoporosis. A human trial reports that finerenone lowers kidney failure risk. Observational studies link SGLT2 inhibitor use with lower risk in adults with chronic kidney disease.
Summary rewritten as its findings changed.
As it read before
Kidney failure is linked with higher mortality in human studies, including older adults with tuberculosis or hip fractures. A human cohort links retinal age gap with higher kidney failure risk, while a human trial reports that finerenone lowers this risk.
Human studies associate kidney failure with disability and osteoporosis, and with higher mortality in older adults with hip fractures, tuberculosis or pneumonia. A human trial reports that finerenone lowers kidney failure risk; observational studies link a larger retinal age gap with higher risk, and clonal hematopoiesis with higher risk in people with chronic kidney disease.
Genetic analyses linked 93 of 2,807 blood proteins to kidney outcomes, with 12 holding up under additional checks.Genetic analyses linked 93 of 2,807 blood proteins to kidney outcomes, with 12 holding up under additional checks.
An exploratory randomized-trial analysis included 3,454 participants with race data and 3,388 with ethnicity data, all with chronic kidney disease and type 2 diabetes.An exploratory randomized-trial analysis included 3,454 participants with race data and 3,388 with ethnicity data, all with chronic kidney disease and type 2 diabetes.
A retrospective cohort study of 1,269 people with Alzheimer disease found neither psychiatric diagnoses nor recorded psychiatric drug exposure independently predicted…A retrospective cohort study of 1,269 people with Alzheimer disease found neither psychiatric diagnoses nor recorded psychiatric drug exposure independently predicted survival over a median 112 months.
Who was studied1,269 patients with Alzheimer disease, median 112 months
What changedPsychiatric diagnoses did not independently predict death from any cause after accounting for dementia severity, demographic factors, and medical conditions
The catchDiagnosis codes did not measure the severity of active psychiatric or behavioral symptoms
Patients whose estimated age exceeded their actual age by more than five years had higher 30-day death odds than other patients (odds ratio 1.69).Patients whose estimated age exceeded their actual age by more than five years had higher 30-day death odds than other patients (odds ratio 1.69).
Household income below $25,000, versus $200,000 or more, was linked to sustained kidney decline with an adjusted hazard ratio of 3.57.Household income below $25,000, versus $200,000 or more, was linked to sustained kidney decline with an adjusted hazard ratio of 3.57.